The use of benzodiazepines in the context of Coronavirus related severe acute respiratory syndrome: a case report
| dc.creator | Jadison Luiz Barbosa Junior | |
| dc.creator | Paulo Henrique Teixeira do Prado | |
| dc.creator | Thales Pimenta de Figueiredo | |
| dc.creator | Caio Hage Chahine Kubrusly | |
| dc.creator | Izabela Maria Seabra Leite | |
| dc.creator | Luiz Filipe Silva Cororino Couto | |
| dc.creator | Paulo Marcos Brasil Rocha | |
| dc.date.accessioned | 2024-09-25T21:17:44Z | |
| dc.date.accessioned | 2025-09-09T00:39:18Z | |
| dc.date.available | 2024-09-25T21:17:44Z | |
| dc.date.issued | 2023 | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.30654/MJPMH.10042 | |
| dc.identifier.issn | 2474-7564 | |
| dc.identifier.uri | https://hdl.handle.net/1843/76886 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Mathews Journal of Psychiatry & Mental Health | |
| dc.rights | Acesso Aberto | |
| dc.subject | Covid-19 | |
| dc.subject | Ansiedade | |
| dc.subject | Pânico | |
| dc.subject | Benzodiazepinas | |
| dc.subject.other | Covid-19 | |
| dc.subject.other | Anxiety | |
| dc.subject.other | Panic | |
| dc.subject.other | Benzodiazepine | |
| dc.subject.other | Respiratory | |
| dc.title | The use of benzodiazepines in the context of Coronavirus related severe acute respiratory syndrome: a case report | |
| dc.type | Artigo de periódico | |
| local.citation.issue | 3 | |
| local.citation.volume | 8 | |
| local.description.resumo | COVID-19 pandemic increased depression and anxiety worldwide and, although benzodiazepines are effective against acute anxiety, they are known to compromise respiratory physiology. Currently, however, no firm guidelines for benzodiazepine use in people with acute COVID-19 are available and there is sparse medical literature regarding benzodiazepine use in patients with active COVID-19 infection and acute anxiety symptoms. Therefore, we report in this correspondence a remarkable case regarding the parsimonious yet safe use of lorazepam for recurrent panic attacks during the course of active COVID-19 infection with severe acute respiratory syndrome. Benzodiazepines not only ceased panic attacks, but also improved respiratory parameters, as patient became less agitated and stopped manipulating his noninvasive ventilation devices. We further performed a narrative review of the literature, searching for studies regarding benzodiazepine use for acute anxiety in patients with COVID-19. | |
| local.identifier.orcid | https://orcid.org/0000-0003-0944-5447 | |
| local.identifier.orcid | https://orcid.org/0000-0002-0337-1371 | |
| local.identifier.orcid | https://orcid.org/0000-0002-0600-9052 | |
| local.identifier.orcid | https://orcid.org/0000-0003-2314-8588 | |
| local.publisher.country | Brasil | |
| local.publisher.department | MED - DEPARTAMENTO DE SAÚDE MENTAL | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.mathewsopenaccess.com/full-text/the-use-of-benzodiazepines-in-the-context-of-coronavirus-related-severe-acute-respiratory-syndrome-a-case-report |
Arquivos
Pacote original
1 - 1 de 1
Carregando...
- Nome:
- The use of benzodiazepines in the context of Coronavirus related severe acute respiratory syndrome_ a case report.pdf
- Tamanho:
- 146.39 KB
- Formato:
- Adobe Portable Document Format
Licença do pacote
1 - 1 de 1